Featured series 
Tag: Office of Technology Development
-
Science & Tech
A matter of vision
Federico Capasso believed a flat lens could revolutionize advanced products, devices. But he needed help innovating one, and getting it to market.
-
Science & Tech
A versatile vessel for next-gen therapeutics
The startup company Vesigen will develop and commercialize the drug-delivery technology created in the lab of Harvard Chan School Professor Quan Lu.
-
Health
Injections to become pills, in vision of Harvard-launched startup
New formulations enable oral delivery of therapeutics traditionally delivered intravenously.
-
Health
From the lab to COVID front lines
Aldatu Biosciences, a company born in Harvard’s labs and nurtured in its entrepreneurial ecosystem, helps the region ramp up COVID-19 testing.
-
Science & Tech
Study looks to genome editing to treat deadly degenerative disorder
Harvard stem-cell research receives support from Sarepta Therapeutics for work on Duchenne muscular dystrophy.
-
Science & Tech
New hope for sensory calm
Harvard professors David Ginty and Lauren Orefice describe how their innovations present a novel approach to treating tactile hypersensitivity in patients with autism-spectrum disorders.
-
Health
Chemists’ breakthrough in synthesis advances a potent anti-cancer agent
Chemists at Harvard and Eisai, a Japanese pharmaceutical company, have synthesized halichondrin, a potent anti-cancer agent found naturally in sea sponges. Because of the molecule’s “fiendishly complex” design, the feat took three decades.
-
Science & Tech
‘Any patient with any disease’
Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”
-
Work & Economy
Swimming toward a biotech startup
Harvard researchers get advice from big fish on how to make their projects a biotech reality at the Guppy Tank event sponsored by Harvard’s Office of Technology Development and LabCentral in Cambridge.
-
Health
The science, business of aging
A half-day conference at Harvard Business School examined the growing promise of research on aging and the potential of now-experimental interventions to one day ease the burdens of infirmity.
-
Health
Food for thought on new ideas
At Harvard-backed “Guppy Tank” sessions, proposals for a new diet that restricts proteins and essential amino acids instead of calories and nutritional supplements to counteract the negative effects of sleep deprivation got feedback from the pros.
-
Health
Beam Therapeutics receives Harvard license
Harvard University has granted a worldwide license to Beam Therapeutics Inc. to develop and commercialize a suite of revolutionary DNA base editing technologies for treating human disease.
-
Science & Tech
Novel cancer treatment gets major boost
The Wyss Institute and Harvard John A. Paulson School of Engineering and Applied Sciences announced Novartis will have access to commercially develop their therapeutic, biomaterial-based cancer vaccine technology.
-
Science & Tech
Seeding startups
For advanced technologies across the University, a new entrepreneur-in-residence program launched by Harvard Office of Technology Development might offer a crucial bridge to commercial development.
-
Science & Tech
Onward and upward, robots
The first article in a series on cutting-edge research at Harvard explores advances in robotics.
-
Health
Heading off the post-antibiotic age
Antibiotic resistance has the potential to take millions of lives by 2050 if nothing is done to address the problem, Anthony Fauci, the head of the National Institutes of Health’s Institute of Allergy and Infectious Diseases, said at Harvard Business School.
-
Health
How old can we get? It might be written in stem cells
No clock, no crystal ball, but lots of excitement — and ambition — among Harvard scientists
-
Science & Tech
A platform for rapid innovation
Harvard’s Office of Technology Development has established a collaborative research agreement with Facebook, which establishes a platform to quickly and easily pursue joint or sponsored research projects with the company.
-
Health
Tackling blood diseases, immune disorders
Startup Magenta Therapeutics licenses technologies from Harvard, Massachusetts General Hospital, and Boston Children’s Hospital that could help transform treatment.
-
Health
The knotty problem of bringing regenerative medicine to market
Leaders from the scientific and business world gathered at Harvard Business School on Oct. 6 to examine regenerative medicine’s scientific and commercial promise.
-
Science & Tech
Defending breakthrough research
Harvard initiates patent infringement suits to protect inventors’ rights in computer-chip technology.
-
Health
A new platform for discovering antibiotics
Harvard chemists have created a platform for discovering antibiotics that they hope will shorten the time and difficulty involved in measuring their effectiveness, even as the body’s resistance to current antibiotics is rising.
-
Health
Harvard licenses genotyping platform
Harvard University has granted a license to Aldatu Biosciences Inc., an early-stage diagnostics development company, for a novel genotyping platform that may help clinicians treating HIV to determine more quickly the most effective medication for each patient.
-
Science & Tech
Advancing ingenuity
Between academic discovery and product development lurks a lull in research funding that inventors call the “chasm of death,” where a prototype or a proof of concept can feel just…
-
Health
A bridge for promising research
Twelve advanced research projects aimed at developing new therapies and diagnostics receive support from Harvard’s Blavatnik Biomedical Accelerator.
-
Science & Tech
Accelerator Fund boosts Harvard tech startups
At Harvard, the Accelerator Fund boosts technologies in engineering and physical sciences, and helps launch companies in robotics, 3-D printing, and materials discovery.
-
Nation & World
Who needed a stapler?
Harvard Professors Eric Mazur and Gary King, together with postdoctoral fellow Brian Lukoff, took an idea about how to change classroom teaching and created a company based on it. When the company sold last spring, it didn’t even own a stapler.
-
Science & Tech
Fueling the entrepreneurial spirit
A growing number of Harvard faculty members, fellows, and even students are looking to take their innovative ideas a step further and bring them to the marketplace.
-
Health
Potential diabetes breakthrough
Researchers at the Harvard Stem Cell Institute have discovered a hormone that holds promise for a dramatically more effective treatment of type 2 diabetes, a metabolic illness afflicting an estimated 26 million Americans.
-
Science & Tech
Robot hands gain a gentler touch
Researchers at the Harvard School of Engineering and Applied Sciences have developed an inexpensive tactile sensor for robotic hands that is sensitive enough to turn a brute machine into a dexterous manipulator.
